{"id":"https://openalex.org/W7225639964","doi":"https://doi.org/10.5281/zenodo.24080875","title":"Single\u2011Nucleus Genomic Profiling of HR+/HER2\u2013 Breast Tumors Revealed Limited Intratumoral Genetic Heterogeneity in Early\u2011Stage Disease","display_name":"Single\u2011Nucleus Genomic Profiling of HR+/HER2\u2013 Breast Tumors Revealed Limited Intratumoral Genetic Heterogeneity in Early\u2011Stage Disease","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225639964","doi":"https://doi.org/10.5281/zenodo.24080875"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.24080875","doi":"https://doi.org/10.5281/zenodo.24080875","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24080875","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Preprint"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.24080875","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007940997","display_name":"Andrey A. Yurchenko","orcid":"https://orcid.org/0000-0002-2239-6902","observed_orcids":["https://orcid.org/0000-0002-2239-6902"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Yurchenko, Andrey","raw_affiliation_strings":["Institut Gustave Roussy"],"raw_orcid":"https://orcid.org/0000-0002-2239-6902","affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy","institution_ids":["https://openalex.org/I2801843802"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5007940997"],"corresponding_institution_ids":["https://openalex.org/I2801843802"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hr-her2-breast-cancer","display_name":"hormone receptor-positive HER2-negative breast cancer","score":0.9860000014305115},{"id":"https://openalex.org/keywords/intratumor-heterogeneity","display_name":"intratumoral heterogeneity","score":0.9929999709129333},{"id":"https://openalex.org/keywords/tumor-evolution","display_name":"tumor evolution","score":0.7310000061988831},{"id":"https://openalex.org/keywords/subclonal-architecture","display_name":"subclonal architecture","score":0.8640000224113464},{"id":"https://openalex.org/keywords/copy-number-alterations","display_name":"copy number alterations","score":0.9649999737739563},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.8309999704360962},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.9860000014305115},{"id":"https://openalex.org/keywords/esr1-mutations","display_name":"ESR1 mutations","score":0.9160000085830688},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.902999997138977},{"id":"https://openalex.org/keywords/tumor-size-and-grade","display_name":"tumor size and grade","score":0.5989999771118164}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6800000071525574},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6186000108718872},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5889000296592712},{"id":"https://openalex.org/C134305767","wikidata":"https://www.wikidata.org/wiki/Q725508","display_name":"Somatic cell","level":3,"score":0.5346999764442444},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.5178999900817871},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.506600022315979},{"id":"https://openalex.org/C64618202","wikidata":"https://www.wikidata.org/wiki/Q3733697","display_name":"Genetic heterogeneity","level":4,"score":0.46149998903274536},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.45680001378059387},{"id":"https://openalex.org/C3018028425","wikidata":"https://www.wikidata.org/wiki/Q15917291","display_name":"Tumor heterogeneity","level":3,"score":0.42160001397132874},{"id":"https://openalex.org/C113968399","wikidata":"https://www.wikidata.org/wiki/Q7559241","display_name":"Somatic evolution in cancer","level":3,"score":0.37450000643730164},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3714999854564667},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.35580000281333923},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.35280001163482666},{"id":"https://openalex.org/C143589142","wikidata":"https://www.wikidata.org/wiki/Q2617554","display_name":"Loss of heterozygosity","level":4,"score":0.34769999980926514},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3452000021934509},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3336000144481659},{"id":"https://openalex.org/C2910240311","wikidata":"https://www.wikidata.org/wiki/Q5418641","display_name":"Mutation Accumulation","level":4,"score":0.3206999897956848},{"id":"https://openalex.org/C2777306565","wikidata":"https://www.wikidata.org/wiki/Q15917291","display_name":"Tumour heterogeneity","level":3,"score":0.31040000915527344},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.2971999943256378},{"id":"https://openalex.org/C120821319","wikidata":"https://www.wikidata.org/wiki/Q1501491","display_name":"Copy-number variation","level":4,"score":0.29350000619888306},{"id":"https://openalex.org/C2780265364","wikidata":"https://www.wikidata.org/wiki/Q5009957","display_name":"CDKN2A","level":3,"score":0.2921999990940094},{"id":"https://openalex.org/C124942203","wikidata":"https://www.wikidata.org/wiki/Q656638","display_name":"Comparative genomic hybridization","level":4,"score":0.2838999927043915},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.2777000069618225},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.2734000086784363},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.27250000834465027},{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.2671000063419342},{"id":"https://openalex.org/C10590036","wikidata":"https://www.wikidata.org/wiki/Q417664","display_name":"Exome","level":5,"score":0.26339998841285706},{"id":"https://openalex.org/C16671776","wikidata":"https://www.wikidata.org/wiki/Q5420592","display_name":"Exome sequencing","level":4,"score":0.25839999318122864},{"id":"https://openalex.org/C98638677","wikidata":"https://www.wikidata.org/wiki/Q2067051","display_name":"Mutation rate","level":3,"score":0.2556999921798706},{"id":"https://openalex.org/C7602840","wikidata":"https://www.wikidata.org/wiki/Q746284","display_name":"Gene duplication","level":3,"score":0.25429999828338623},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.2513999938964844}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.24080875","doi":"https://doi.org/10.5281/zenodo.24080875","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24080875","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Preprint"},{"id":"doi:10.5281/zenodo.24080877","doi":"https://doi.org/10.5281/zenodo.24080877","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24080877","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Preprint"}],"best_oa_location":{"id":"doi:10.5281/zenodo.24080875","doi":"https://doi.org/10.5281/zenodo.24080875","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24080875","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Preprint"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4306404840","https://openalex.org/W2892120153","https://openalex.org/W2890777724","https://openalex.org/W2129288227","https://openalex.org/W2274849208","https://openalex.org/W7136414336","https://openalex.org/W2592681781","https://openalex.org/W2621985408","https://openalex.org/W7131240344","https://openalex.org/W2406335977"],"abstract_inverted_index":{"Hormone":[0],"receptor-positive,":[1],"HER2-negative":[2],"(HR+/HER2-)":[3],"breast":[4,10,48,220],"cancer":[5,11,221],"is":[6,211],"the":[7,14,78,157,170],"most":[8],"common":[9],"subtype,":[12],"yet":[13],"level":[15],"of":[16,24,77,87,156,215],"intratumoral":[17,72],"heterogeneity,":[18],"subclonal":[19,183],"architectures":[20,85],"and":[21,66,69,112,115,137,167],"temporal":[22],"ordering":[23],"mutations":[25,132,139,147,185],"driving":[26],"its":[27],"progression":[28],"remain":[29],"poorly":[30],"understood.":[31],"To":[32],"resolve":[33],"these":[34,203],"evolutionary":[35],"trajectories,":[36],"we":[37],"utilized":[38],"targeted":[39],"single-nucleus":[40],"DNA":[41],"sequencing":[42],"on":[43],"228":[44],"early-stage,":[45],"primary":[46],"HR+/HER2-":[47,219],"tumors,":[49,190],"capturing":[50],"over":[51],"757,000":[52],"individual":[53],"nuclei.":[54],"We":[55,122],"developed":[56],"a":[57],"novel":[58],"pipeline":[59],"integrating":[60],"somatic":[61],"varians,":[62],"copy-number":[63],"alterations":[64],"(CNAs)":[65],"germline":[67],"variants,":[68],"identified":[70],"detectable":[71],"heterogeneity":[73],"(ITH)":[74],"in":[75,150,154,188,213],"25%":[76],"cohort.":[79,158],"Most":[80],"polyclonal":[81],"tumors":[82,216],"exhibited":[83],"simple":[84],"consisting":[86],"two":[88],"subclones,":[89],"with":[90,164,169,178],"divergence":[91],"driven":[92],"primarily":[93],"by":[94],"CNAs":[95],"rather":[96],"than":[97],"driver":[98,146],"mutations.":[99],"Evolutionary":[100],"timing":[101],"analyses":[102],"demonstrated":[103],"that":[104,192,206],"major":[105],"arm-level":[106],"events":[107],"(such":[108],"as":[109],"1q":[110],"gain":[111],"16q":[113],"loss)":[114],"TP53mutations":[116],"were":[117,134,141,148,186],"predominantly":[118],"early,":[119],"truncal":[120],"events.":[121],"also":[123],"observed":[124],"hotspot-specific":[125],"clonality":[126],"for":[127],"PIK3CA":[128,145],"mutations,":[129],"where":[130],"kinase-domain":[131],"(H1047R)":[133],"mostly":[135],"clonal,":[136],"helical-domain":[138],"(E545K)":[140],"frequently":[142],"subclonal.":[143],"Additionally,":[144],"detected":[149,187],"normal":[151],"diploid":[152],"cells":[153],"3.9%":[155],"While":[159],"ITH":[160],"was":[161,174],"positively":[162],"associated":[163,177],"tumor":[165,171],"size":[166],"negatively":[168],"grade,":[172],"it":[173],"not":[175],"significantly":[176],"overall":[179],"survival.":[180],"Importantly,":[181],"minor":[182],"ESR1":[184],"treatment-naive":[189],"indicating":[191],"endocrine":[193],"resistance":[194],"mechanisms":[195],"can":[196],"arise":[197],"prior":[198],"to":[199],"therapeutic":[200],"pressure.":[201],"Together,":[202],"findings":[204],"reveal":[205],"functionally":[207],"significant":[208],"clonal":[209],"diversity":[210],"established":[212],"quarter":[214],"early":[217],"during":[218],"evolution.":[222]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}